As of Apr 17
| -0.03 / -2.10%|
The 6 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 5.00, with a high estimate of 8.00 and a low estimate of 2.00. The median estimate represents a +257.14% increase from the last price of 1.40.
The current consensus among 7 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.